Brilacidin, a novel antifungal agent against Cryptococcus neoformans

C Diehl, CF Pinzan, PA de Castro, E Delbaje… - Mbio, 2024 - journals.asm.org
Cryptococcus neoformans causes cryptococcosis, one of the most prevalent fungal
diseases, generally characterized by meningitis. There is a limited and not very effective …

Antimicrobial peptides: novel source and biological function with a special focus on entomopathogenic nematode/bacterium symbiotic complex

S De Mandal, AK Panda, C Murugan, X Xu… - Frontiers in …, 2021 - frontiersin.org
The rapid emergence of multidrug resistant microorganisms has become one of the most
critical threats to public health. A decrease in the effectiveness of available antibiotics has …

Novel antimicrobial peptide DvAMP serves as a promising antifungal agent against Cryptococcus neoformans

L Yang, Z Tian, W Zhao, J Zhang, C Tian, L Zhou… - Bioorganic …, 2023 - Elsevier
Cryptococcus neoformans is an important opportunistic human fungal pathogen that causes
cryptococcosis in immunocompromised patients. However, the number of drugs for the …

Casein kinase 2 complex: a central regulator of multiple pathobiological signaling pathways in Cryptococcus neoformans

Y Choi, SR Yu, Y Lee, AY Na, S Lee, J Heitman, R Seo… - Mbio, 2024 - Am Soc Microbiol
ABSTRACT The casein kinase 2 (CK2) complex has garnered extensive attention over the
past decades as a potential therapeutic target for diverse human diseases, including cancer …

Biofilm Formation and Phospholipase and Proteinase Production in Cryptococcus neoformans Clinical Isolates and Susceptibility towards Some Bioactive Natural …

BN Bisso, AL Makuété, JU Tsopmene… - The Scientific World …, 2023 - Wiley Online Library
Background. Cryptococcosis is one of the most common fungal infections in
immunocompromised patients, which is caused by Cryptococcus neoformans. However …

Discovery of novel orally bioavailable triazoles with potent and broad-spectrum antifungal activity in vitro and in vivo

T Ni, F Xie, Y Hao, L Li, S Zhu, H Wu… - Journal of Medicinal …, 2022 - ACS Publications
In our continuing efforts to discover novel triazoles with improved antifungal activity in vitro
and in vivo, a series of 41 novel compounds containing 1, 2, 3-triazole side chains were …

Isolation and characterization of a broad-spectrum phage SapYZU11 and its potential application for biological control of Staphylococcus aureus

H Wen, L Yuan, J Ye, Y Li, Z Yang, W Zhou - Quality Assurance and …, 2023 - qascf.com
Staphylococcus aureus, a prominent pathogen, is frequently encountered in clinical and
food-processing settings. Given its ability to develop antimicrobial resistance, effective …

Discovery of Novel Tetrazoles Featuring a Pyrazole Moiety as Potent and Highly Selective Antifungal Agents

X Chi, H Zhang, H Wu, X Li, L Li, Y Jiang, T Ni - ACS omega, 2023 - ACS Publications
In pursuit of developing novel azole antifungals with potent activity and high selectivity, a
series of (2 R, 3 S)-3-(substituted-1 H-pyrazol-3-yl)-2-(2, 4-difluorophenyl)-1-(1 H-tetrazol-1 …

Genetic analysis of Hsp90 function in Cryptococcus neoformans highlights key roles in stress tolerance and virulence

C Fu, SR Beattie, AJ Jezewski, N Robbins… - Genetics, 2022 - academic.oup.com
The opportunistic human fungal pathogen Cryptococcus neoformans has tremendous
impact on global health, causing 181,000 deaths annually. Current treatment options are …

Methods for Antifungal Susceptibility Testing of the Cryptococcus neoformans/C. gattii Complex: Strengths and Limitations

A Espinel-Ingroff, E Cantón - Journal of Fungi, 2023 - mdpi.com
When method-dependent categorical endpoints are available, namely either BPs or ECVs,
MICs could aid in selecting the best treatment agent (s). BPs can categorize an isolate as …